Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Subscribe to JNMT RSS feeds
Continuing Education

Nuclear Cardiology, Part III: Scintigraphic Evaluation of Cardiac Perfusion

Hendrik Everaert, Alex Maes, Anne-Sophie Hambye, Lisbeth Mesotten, Luc Mortelmans and Philippe R. Franken
Journal of Nuclear Medicine Technology September 1998, 26 (3) 164-169;
Hendrik Everaert
Division of Nuclear Medicine, University Hospital, Free University of Brussels, Brussels; Division of Nuclear Medicine, University Hospital, Catholic University of Leuven, Leuven; and Division of Nuclear Medicine, Middelheim Hospital, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Maes
Division of Nuclear Medicine, University Hospital, Free University of Brussels, Brussels; Division of Nuclear Medicine, University Hospital, Catholic University of Leuven, Leuven; and Division of Nuclear Medicine, Middelheim Hospital, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Sophie Hambye
Division of Nuclear Medicine, University Hospital, Free University of Brussels, Brussels; Division of Nuclear Medicine, University Hospital, Catholic University of Leuven, Leuven; and Division of Nuclear Medicine, Middelheim Hospital, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisbeth Mesotten
Division of Nuclear Medicine, University Hospital, Free University of Brussels, Brussels; Division of Nuclear Medicine, University Hospital, Catholic University of Leuven, Leuven; and Division of Nuclear Medicine, Middelheim Hospital, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luc Mortelmans
Division of Nuclear Medicine, University Hospital, Free University of Brussels, Brussels; Division of Nuclear Medicine, University Hospital, Catholic University of Leuven, Leuven; and Division of Nuclear Medicine, Middelheim Hospital, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe R. Franken
Division of Nuclear Medicine, University Hospital, Free University of Brussels, Brussels; Division of Nuclear Medicine, University Hospital, Catholic University of Leuven, Leuven; and Division of Nuclear Medicine, Middelheim Hospital, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Objective: After reading Part III of this series of nuclear cardiology articles, the technologist should be able to: (a) compare and contrast radiopharmaceuticals used for myocardial perfusion imaging; (b) describe imaging protocols used for detecting coronary artery disease; and (c) describe imaging patterns seen following reconstruction of myocardial images.

  • myocardial perfusion scintigraphy
  • thallium-201
  • technetium-99m-sestamibi
  • technetium-99m-tetrofosmin
  • coronary artery disease
  • imaging protocols
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 26 (3)
Journal of Nuclear Medicine Technology
Vol. 26, Issue 3
September 1, 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nuclear Cardiology, Part III: Scintigraphic Evaluation of Cardiac Perfusion
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Nuclear Cardiology, Part III: Scintigraphic Evaluation of Cardiac Perfusion
Hendrik Everaert, Alex Maes, Anne-Sophie Hambye, Lisbeth Mesotten, Luc Mortelmans, Philippe R. Franken
Journal of Nuclear Medicine Technology Sep 1998, 26 (3) 164-169;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nuclear Cardiology, Part III: Scintigraphic Evaluation of Cardiac Perfusion
Hendrik Everaert, Alex Maes, Anne-Sophie Hambye, Lisbeth Mesotten, Luc Mortelmans, Philippe R. Franken
Journal of Nuclear Medicine Technology Sep 1998, 26 (3) 164-169;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Root Cause Analysis in Nuclear Medicine for Sentinel Events
  • SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer—Use of Imaging Agents in Therapeutic Drug Development and Approval
  • Diuretic Renal Scintigraphy Protocol Considerations
Show more Continuing Education

Similar Articles

Keywords

  • myocardial perfusion scintigraphy
  • thallium-201
  • technetium-99m-sestamibi
  • technetium-99m-tetrofosmin
  • coronary artery disease
  • imaging protocols
SNMMI

© 2023 Journal of Nuclear Medicine Technology

Powered by HighWire